The Centers for Medicare & Medicaid Services (CMS) has put forth a proposed rule that outlines significant changes to the Medicare Shared Savings Program (Shared Savings Program) for the calendar year (CY) 2024. The aim of these proposed changes is to further advance CMS’ value-based care strategy, promote growth, alignment, and equity in the program, and address concerns raised by stakeholders, particularly accountable care organizations (ACOs). A large part of the strategy refresh for value-based care comes from the bold goal to have all Medicare fee-for-service beneficiaries in a care relationship with accountability for quality and total cost by 2030.

ACOs should review the fee schedule update proposals closely to assess the implications for their specific circumstances. This summary does not include all changes being proposed.

 

Part 1: Advance Investment Payments [1],[2],[3]

The Centers for Medicare & Medicaid Services (CMS) has introduced a transformative approach; a new payment avenue in the form of “advance investment payments” (AIPs) for eligible participants in the Medicare Shared Savings Program (Shared Savings Program). Initially established in the CY 2023 PFS final rule, AIPs are designed to aid accountable care organizations (ACOs) during their transition to performance-based risk. AIP offers new ACOs upfront shared savings payments, aiming to alleviate initial financial burdens and enhance care quality for underserved beneficiaries. This innovative initiative seeks to stimulate ACO formation in underserved regions and foster equitable healthcare access.

To be eligible for AIP, ACOs must be new applicants to the Shared Savings Program and meet specific criteria, such as:

  • Participate in the Medicare Shared Savings Program (MSSP) as an ACO (Basic Level A); ACOs joining at Levels B through E of the BASIC Track will not be eligible to receive all 8 quarterly payments, if any;
  • Inexperience with performance-based risk initiatives;
  • Low revenue status.

The payments must be used to boost care quality and efficiency, addressing both clinical and social determinants of health. CMS’s focus on AIP underscores their commitment to advancing health equity by encouraging ACO participation, particularly in regions facing healthcare disparities. Through AIP, CMS envisions a more inclusive and diverse landscape in the Shared Savings Program, driving positive healthcare outcomes for underserved populations.

Proposed refinements to this payment approach are currently under consideration for ACOs entering agreement periods commencing on January 1, 2024. The refinements include allowing ACOs to move to two-sided model levels within the BASIC track’s glide path in their third performance year after receiving advance investment payments. Additionally, the recoupment of these payments would occur from the shared savings of ACOs choosing early renewal, rather than a direct recoupment process. Reporting requirements for spend plan updates and actual spending information would be expanded, termination policies adjusted, and the option for reconsideration review of payment calculations introduced.

 

Part 2: Redefined Beneficiary Assignment and Enhancements to Financial Benchmarking: Regional Risk Score Cap & Risk Adjustment [4],[5]

CMS is taking steps to restructure the beneficiary assignment process within the Shared Savings Program. Effective from January 1, 2025, CMS proposes adding a third step to the beneficiary assignment methodology to increase accuracy and inclusivity. This proposal will also expand the assignment window from 12 months to 24 months and will specifically account for the role of nurse practitioners, physician assistants, and clinical nurse specialists providing primary care services.. The change is expected to increase access to care for underserved populations, as more beneficiaries will be assigned to ACOs. CMS anticipates that this change could have historically resulted in nearly a 2.9% rise in the national assignable population.

A proposed adjustment to the calculation of the regional component of the three-way blended benchmark update factor is under consideration for agreement periods beginning on January 1, 2024, and subsequent years. This proposal seeks to cap the growth of prospective Hierarchical Condition Category (HCC) risk scores within an ACO’s regional service area. The method draws inspiration from the methodology adopted in the CY 2023 PFS final rule and includes an assessment of the ACO’s aggregate market share. This cap on regional risk score growth would stand independently of the cap on an ACO’s own prospective HCC risk score growth, ensuring uniform application across regions. The objective is to enhance accuracy in regional update factors for ACOs functioning within regions experiencing significant risk score growth. This measure aims to create incentives for ACOs to operate within regions with higher risk score growth, thereby encouraging the provision of quality care for high-risk beneficiaries and attracting new ACO participants.

To bolster risk adjustment within the Shared Savings Program and ensure consistent application of the revised CMS-HCC risk adjustment model (2024 CMS-HCC V28) in the program context, a proposal has been introduced suggesting using the same CMS-HCC risk adjustment model utilized in the performance year for all benchmark years. The proposed phased transition mirrors the process undertaken in Medicare Advantage, wherein the revised 2024 CMS-HCC model will be phased in over three years, comprising 67% of the 2020 CMS-HCC model and 33% of the CMS-HCC model for performance year 2024. Existing ACOs would continue using the current methodology for calculating benchmark year and performance year prospective HCC risk scores, mitigating adverse impacts during the transition period. This approach strives to ensure consistent risk adjustment and equitable benchmarking across the Shared Savings Program.

For agreement periods starting on or after January 1, 2024, when calculating the update factor between a benchmark year three (BY3) and the performance year (PY), this proposed cap will consider two factors:

  • An increase of up to +3% beyond the change in demographic risk score.
  • An adjustment accounting for the ACO’s market share, which will influence the cap’s extent.

This change is likely to impact ACOs in regions where there has been significant risk score growth since BY3. While this modification will not affect most ACOs, its impact will be more pronounced as the gap between benchmark years and performance years increases. CMS’s simulations indicate that around 11% of ACOs could have been subject to this cap for PY 2021.

Lastly, the finalized policies of the CY 2023 PFS rule aimed to reduce negative regional adjustments’ impact for Shared Savings Program participants starting on January 1, 2024. CMS wants to encourage ACOs serving high-cost beneficiaries to join or stay in the program. The proposal seeks to further alleviate this impact, potentially enhancing the attractiveness of program participation. The proposed changes would eliminate downward adjustments for ACOs facing negative benchmark adjustments according to the CY 2023 PFS rule methodology. Furthermore, ACOs with negative regional adjustment and eligible for prior savings adjustment could also benefit as the negative regional adjustment would no longer offset the prior savings adjustment. ACOs with positive regional adjustments would remain unaffected by the proposed changes.

In essence, these financial benchmark adjustments and beneficiary assignment methodology enhancements reflect CMS’s commitment to refining the Shared Savings Program to ensure greater accuracy, fairness, and inclusivity in its operations, thereby benefiting participating ACOs and the beneficiaries they serve.

 

Part 3: Embracing Digital Quality Measurement Submission – Reporting Medicare CQMs and the Alignment with MIPS [6],[7]

CMS is actively pursuing a shift towards electronic clinical quality measures (eCQMs) that involve all-patient, all-payer reporting. The ACO community have spent recent years voicing concerns about the associated time and financial burdens, particularly the effort required to aggregate data from diverse practices with varying electronic health records. This transition implies that ACOs must report on all patients, extending beyond Medicare beneficiaries or those exclusively linked to the ACO’s primary care clinicians. However, this move can inadvertently prompt specialists to provide services typically within the purview of primary care, potentially leading to extra tests that Medicare might not cover. Moreover, ACOs serving traditionally underserved patients might experience unfairly lower scores due to the inability to account for variations in Medicaid or uninsured patient populations.

One of the key proposed changes is the new form of digital quality measurement within the Shared Savings Program for ACOs under the Alternative Payment Model (APM) Performance Pathway (APP) – Medicare Clinical Quality Measures (CQMs). During the performance year 2024, ACOs will be presented with the choice to report quality data through three distinct avenues: CMS Web Interface measures, electronic clinical quality measures (eCQMs), and/or Merit-Based Incentive Payment System (MIPS) clinical quality measures (CQMs) collection types. Moving forward into performance year 2025 and the subsequent years as determined by CMS, ACOs will retain the flexibility to report quality data using eCQMs, MIPS CQMs, and/or Medicare CQMs collection types. This multi-method approach provides ACOs with adaptable options to effectively communicate their quality performance, aligning with the program’s commitment to enhancing patient care and outcomes.

The proposed adoption of Medicare CQMs within the Shared Savings Program serves as a transition collection type for ACOs. This transition aims to equip ACOs with the necessary infrastructure, skills, knowledge, and expertise to report all payer/all patient Merit-Based Incentive Payment System (MIPS) CQMs and electronic Clinical Quality Measures (eCQMs) more effectively. By focusing on Medicare patients with claims encounters with ACO professionals holding specialty designations used in the Shared Savings Program assignment methodology, ACOs can gradually adapt to digital reporting for their Medicare patients without being penalized for serving other patient populations.

The proposal aims to reduce barriers to digital measurement and promote the adoption of advanced technology within the Shared Savings Program. This will enable ACOs to embrace digital reporting for their Medicare patients, without facing potential penalties for serving other patients, encouraging them to adopt modern healthcare technologies.

 

Data Completeness Standard for Medicare CQMs

Performance YearCompleteness Percentage
202475%
202575%
202675%
202780%

To streamline and align the Shared Savings Program with the Merit-Based Incentive Payment System (MIPS), CMS proposes eliminating the program’s certified electronic health record technology (CEHRT) requirements. Instead, they recommend that all MIPS-eligible clinicians and ACO participants report MIPS Promoting Interoperability (PI) performance category measures and requirements to MIPS. This will promote greater use of CEHRT among ACO clinicians.

In conclusion, CMS predicts that these proposed changes will lead to a surge in ACO participation, estimated to increase by 10% to 20%. As more ACOs join the Shared Savings Program, the number of beneficiaries receiving coordinated care from ACOs is expected to rise significantly, promoting better patient outcomes and healthcare cost savings.

The proposed rule signifies a comprehensive effort by CMS to enhance the Medicare Shared Savings Program for 2024. By embracing digital quality measurement, refining financial benchmarking, and implementing beneficiary assignment enhancements, CMS seeks to boost ACO participation and improve patient care. CMS is actively seeking public comments on potential future developments for the Shared Savings Program. Topics open for feedback include introducing a higher-risk track, modifying the prior savings adjustment, refining benchmark update factors, and encouraging collaboration between ACOs and community-based organizations. The comment period closes on September 11, 2023.

 

For any questions on the ever-evolving policies affecting ACOs or the Shared Savings Program, please contact Kelly Conroy or Daniela Yusufbekova.

Kelly Conroy
(561)385-7566
KConroy@AskPHC.com

Daniela Yusufbekova
(561)445-8303
DYusufbekova@AskPHC.com

 

 

[1] https://www.cms.gov/files/document/aip-guidance.pdf

[2] https://www.cms.gov/files/document/mssp-fact-sheet-cy-2023-pfs-final-rule.pdf

[3] https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2024-medicare-physician-fee-schedule-proposed-rule-medicare-shared-savings-program

[4] https://www.cms.gov/files/document/mssp-fact-sheet-cy-2023-pfs-final-rule.pdf

[5] https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2024-medicare-physician-fee-schedule-proposed-rule-medicare-shared-savings-program

[6] https://qpp.cms.gov/mips/app-quality-requirements

[7] https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2024-medicare-physician-fee-schedule-proposed-rule-medicare-shared-savings-program

Abstract

On May 15, 2023, Envision Healthcare Corp. (“Envision”) announced that it and several of its subsidiaries had filed voluntary petitions for reorganization under Chapter 11 of the United States Bankruptcy Code.  This news prompted a swift reaction within the healthcare industry as Envision reports itself as “one of the nation’s leading medical groups, delivering physician and advanced practice provider care in settings where patients have the most acute and life-changing needs – emergency departments, surgical suites, intensive care units and birthing suites – through Envision Physician Services.”[1]   Because of its large role in the successful functioning of emergency departments (“EDs”) across the country, Envision is often regarded as crucial to the functioning of the country’s healthcare system.  Because of this role, Envision’s petition for bankruptcy has caused widespread speculation as to the direction of emergency care for patients, particularly as the industry’s provider workforce had already been strained in recent years due to a myriad of issues.

In this article, we delve into the multifaceted obstacles that EDs encounter daily, discuss recent events and trends that are materially affecting emergency care delivery, examine the financial and regulatory repercussions associated with these issues, explore the recent collapse of provider staffing firms, consider key elements of provider staffing and compensation, and discuss the urgent need for viable solutions into the future. Understanding these challenges will remain crucial as we work toward bolstering ED coverage to ensure the well-being of both patients and providers.

 

Background

Overview of Emergency Care

Contrasted with other medical specialties, emergency patients can present with a wide array of acute symptoms and can do so at any time, at any age, and with any co-morbidity.  Because the nature of emergency medicine ensures a constant state of unpredictability, the delivery of care in this setting remains a formidable challenge.  Thus, while hospital EDs are crucial for healthcare delivery and represent a lifeline for patients, management of this care is oftentimes characterized as a battleground.

As has been argued by industry experts, an “effective emergency care system serves three major functions: (i) it serves as a primary point of entry into the healthcare system for all patients with symptomatic conditions, (ii) it provides time sensitive management of acute exacerbations of chronic disease, and (iii) it serves as a crucial safety net for patients without other linkages to healthcare.”[2]  The passage of the Emergency Medical Treatment and Active Labor Act (“EMTALA”) in 1986 further clarified this role as it requires hospital EDs that accept payments from Medicare to provide care to any patient seeking treatment for a medical condition, regardless of citizenship, legal status, or ability to pay.[3]  This dynamic function underscores the importance of maintaining robust staffing and optimal functioning within EDs, thereby safeguarding the accessibility and quality of healthcare services.

Despite its importance, factors such as the rapid influx of patients, the acuity of critical cases, and continuously changing dynamics ensure constant pressure on healthcare facilities and create a daunting landscape that necessitates a resilient and well-prepared staff.  Therefore, even with the challenges of emergency care, ED provider staffing serves as a critical function to the overall delivery of healthcare nationwide.

Trends Affecting ED Care Delivery

Despite the importance of ED provider staffing, several factors have contributed to its uncertainty and erosion in recent years.  While Covid-19 undoubtedly presented a seemingly insurmountable obstacle to healthcare delivery, several issues pertinent to ED care had been looming prior to the impact of the pandemic.  Specifically, healthcare providers were already grappling with issues such as an aging population, increased patient obesity, a rise in co-morbidities, physician shortages, and provider burnout.  The aggregate effect of these trends seemed to point to an inevitable intersection of increased demand for healthcare services with a simultaneous decrease in provider availability.

While this crossroad has been a cause for concern for years, the Covid-19 pandemic only further exacerbated these developments.  The potential repercussions of a void in patient care are alarming in any instance, but particularly given the country’s rise in co-morbidities and the elderly patient population.[4]  Ensuring the delivery of timely, high-quality care is becoming a more urgent concern, especially given complications intensified by the pandemic and the collapse of notable provider staffing firms.

While EDs scramble to formulate solutions ensuring patient access to necessary care, they have continued to experience overcrowding, a trend only worsened by Covid-19.  ED crowding, a critical issue plaguing organizations worldwide, is characterized by an overwhelming demand for emergency services that surpasses the available resources for patient care in the ED, hospital, or both.[5]  This relentless pressure on EDs has far-reaching consequences, including adverse effects on morbidity, mortality, medical error rates, staff burnout, and excessive costs. Moreover, the arrival of the Covid-19 pandemic has only exacerbated the challenges associated with crowding, leading to a substantial increase in overall ED patient lengths of stay (“LOS”).[6]

According to analysis by the Journal of the American College of Emergency Physicians Open (“JACEP Open”), ED LOS was “significantly higher during the Covid-19 period compared to the pre-Covid-19 period”.[7]  These indicators are alarming given the fact that increased LOS leads to further ED overcrowding.  Because EDs represent the front line of the healthcare system, this strain on hospital resources inevitably trickles down to patient experience and outcomes.  The following table, compiled as part of the JACEP Open assessment, illustrates the distinction between LOS prior to and during the pandemic.[8]

 

 

Despite the impact of the pandemic, alarming statistics revealed that even before the Covid-19 outbreak, over 90% of U.S. EDs were frequently operating under significant stress, pushing them to their breaking point.[9]  As the primary entry point into the healthcare system for most SARS-CoV-2-infected patients, EDs faced unparalleled strain during the pandemic, exposing their vulnerabilities and limitations in responding effectively and safely to such crises within severely crowded environments.[10]  The combination of ED crowding and the exigencies of the Covid-19 virus has shed a glaring light on the urgent need for sustainable solutions to safeguard the efficiency and effectiveness of emergency care delivery.

In an attempt to effectuate such care and expand patient access to emergency providers, many organizations are reviewing their provider staffing model to better utilize advanced practice clinicians (“APCs”) including physician assistants and nurse practitioners.  While ED staffing is a pivotal factor in delivering efficient and high-quality patient care, it remains a constant challenge for healthcare institutions to maintain optimal nurse-to-patient ratios. In recent years, nursing organizations, labor unions, and policymakers have been pushing for mandated nurse-to-patient ratios in EDs, advocating for a range from 1:4 for general ED patients to 1:1 for trauma cases.[11]

In spite of the importance of ED providers, the emergence of Covid-19 has intensified the strain on ED staffing, compelling a significant portion of health care workers to contemplate leaving the profession due to the overwhelming stress and demands of the crisis.  A troubling Kaiser Family Foundation/Washington Post poll revealed that approximately three in ten health care workers considered abandoning their careers, while about six in ten reported a detrimental impact on their mental health due to pandemic-related stress. The relentless workforce challenges posed by the pandemic have also come at a staggering financial cost, with hospitals collectively incurring $24 billion in staffing shortages and an additional $3 billion in acquiring personal protective equipment (“PPE”) to safeguard their staff.[12]  The pressing need to address ED staffing shortages and support the well-being of healthcare professionals has become more apparent than ever, underscoring the urgency for strategic interventions to ensure sustainable and resilient emergency care systems.

 

Financial Impact of ED Staffing Challenges

The ramifications of the ED staffing crisis extend far beyond the realm of patient care, significantly affecting the financial health of healthcare institutions. The scarcity of qualified medical personnel has led to a surge in wages as hospitals endeavor to attract and retain skilled staff, imposing a substantial burden on their resources.

According to Fitch Ratings, labor expenses (encompassing salaries and benefits) constitute the largest expense category for hospitals, accounting for over 50% of their total expenditures. Between February 2020 and August 2021, average hourly wages for hospital employees have skyrocketed by 8.5%, and there are no indications of this inflationary trend abating anytime soon. The escalating costs are set to deal a severe blow to hospital margins in the coming year, as projected by credit rating agency Moody’s, owing to a combination of wage inflation, the mounting expenses incurred in hiring expensive contract provider staffing firms, and the implementation of additional worker benefits to retain employees.[13]

As the financial strain continues to escalate, healthcare institutions find themselves at a crossroads, navigating the delicate balance between sustaining operational viability and ensuring the delivery of quality patient care amidst the relentless challenges of ED staffing.  The collapse of ED staffing firms is causing further concern for provider availability, a fact which underscores the importance of strategically planning for provider retention as well as leveraging the work of APCs to alleviate burdens placed on ED physicians.

 

Case Study: Envision Bankruptcy

In the midst of the already stressed ED environment, Envision jolted the industry with its recent decision to seek Chapter 11 bankruptcy protection.  Given its reputation as one of the nation’s prominent healthcare staffing firms, this development has triggered concerns among industry observers, raising questions about the financial stability of other third-party staffing agencies.  On the heels of the Envision announcement, American Physician Partners (“APP”), another medical staffing company serving numerous hospitals across 18 states, announced that it plans to wind down its operations and transition its hospital contracts.  APP had grown rapidly since it was founded in 2015, with its revenue jumping 154.2% from 2018 to 2021 – a fact which made it one of Nashville’s ten largest privately owned businesses.[14]  Citing ongoing financial challenges amongst its struggle to repay its overdue loans, the company’s closure came swiftly, with the transition starting as of July 31, 2023.[15]  Yet another example following Envision’s announcement, this trend is troubling for a healthcare system already struggling to staff EDs in an effort to meet increased patient demand.

Given that both companies folded in rapid succession citing financial troubles, the underlying business model could be a significant part of the cause.  Oftentimes, the structure of healthcare staffing companies entails carrying significant debt and maintaining relatively lower cash reserves.  This mode of business can expose these firms to greater risk, particularly when dealing with transient providers, leading to fluctuations in cash flow.  For Envision, these challenges manifested in a series of financial setbacks, culminating in the bankruptcy filing.

One key factor which reportedly contributed to Envision’s financial troubles was the enactment of the No Surprises Act (“NSA”). Prior to the NSA, patients seeking treatment at in-network healthcare facilities (including EDs) could be billed at out-of-network rates if the agency through which the facility staffed its services was not in-network.  The NSA aimed to curb such unexpected out-of-network bills, providing consumer protection against surprise medical expenses.

However, Envision contended that the NSA’s implementation deviated from its intended purpose, allowing health insurers to delay, reduce, or deny payments.  According to Envision, these factors led to substantial losses for the company. Alleged underpayments and prolonged waiting periods for reimbursements reportedly amounted to hundreds of millions of dollars in financial losses for Envision, contributing significantly to the dire financial situation that culminated in the bankruptcy filing.[16]

Similarly, the closure of APP adds to the list of provider staffing entities grappling with financial challenges in the wake of the NSA taking effect on January 1, 2022.  While the goal of the legislation aimed at curbing surprise medical bills for emergency services and out-of-network care, these organizations report that it has resulted in significant financial strain.[17]  The distress faced by APP, coupled with similar instances such as Envision’s bankruptcy filing, highlights the substantial impact of regulatory changes on the financial stability of healthcare staffing firms.  The ripple effect of this type of financial turmoil has direct implications for ED staff burnout, as the uncertainty surrounding the viability of staffing companies may heighten the stress and apprehension experienced by frontline healthcare professionals.

The high-profile Envision bankruptcy – as well as the rapid closure of APP –  serves as a cautionary tale, prompting a closer examination as to the financial vulnerabilities of healthcare staffing firms and raising concerns about the broader implications for the industry as it grapples with evolving regulatory landscapes and financial challenges.  In the event continued workforce strain amongst ED providers has a material impact on patient care, the effect may lead to problems with the overall delivery of healthcare.  Thus, the implications of Covid-19 and the Envision bankruptcy only further exacerbate an already existing set of troubling circumstances.

 

Comments from a Valuation Perspective

As the landscape of ED care evolves, so too will the considerations around provider compensation.  As previously discussed, a certain amount of uncertainty exists regarding wages in the wake of the pandemic.  Particularly as issues such as provider shortages, burnout, and increased patient demand continue to persist, healthcare organizations will be fervently working to ensure its facilities are staffed with adequate providers to achieve necessary patient access.

While the need for providers is anticipated to persist on an ongoing basis, hospitals and health systems must nonetheless adhere to regulatory requirements, one of which is the need to ensure provider compensation (i.e., in certain circumstances) is consistent with fair market value (“FMV”).  While the determination of FMV does not require review by an outside party, many organizations are managing their risk exposure by relying on legal counsel and valuation professionals to construct and review agreements, including their financial terms.

From a valuator’s standpoint, determining FMV compensation for physicians and APCs involves a complex process that requires a comprehensive analysis of various factors.   Several statutory, regulatory and administrative definitions exist related to the concept of FMV.  Given said definitions, valuators will generally gather a reasonable knowledge of available, relevant factors associated with a subject arrangement.  Based on this knowledge, they then derive an estimate of value (i) as if there was no compulsion to buy or sell, and (ii) without taking into consideration the business either party could generate for the other.  In other words, FMV refers to the price at which two independent and knowledgeable parties would agree to a transaction, reflecting the true value of the services rendered.

When it comes to compensating healthcare providers, valuations should account for numerous factors, including the specific qualifications and experience of providers, regional market conditions, patient volume, specialty demand, and the complexity of the healthcare facility’s case mix.  In addition to factors specific to each individual subject arrangement, key considerations generally taken into account by valuators and legal counsel include:

  • Ensuring that the compensation arrangements adhere to strict regulatory guidelines (e.g., state-specific requirements in addition to the Stark Law, the Anti-Kickback Statute, and rules for 501(c)(3) organizations) to avoid potential legal ramifications;
  • Considering any specific requirements or restrictions related to compensation set forth by payors, accreditation bodies, and industry standards; and,
  • Accounting for the type of arrangement and any ascertainable quality metrics amid the evolving healthcare landscape in which shifting reimbursement models and changing workforce dynamics are factors.

The valuator’s expertise is pivotal in ensuring that the compensation packages strike a balance between attracting and retaining skilled healthcare professionals while safeguarding the organization’s financial sustainability. With the growing emphasis on healthcare value and cost-effectiveness, valuators will often gauge the competitive nature of the market to ensure that the compensation aligns with comparable rates in the region while complying with FMV standards. A thorough and meticulous valuation process ultimately lays the foundation for equitable and compliant compensation structures that foster a strong and sustainable healthcare workforce.

Specific to ED compensation considerations, these provider compensation arrangements have often been historically structured on a “per shift” basis.  These shifts were almost exclusively covered by providers in the local market.  Because ED physicians and APCs are providing hospital coverage for emergent patient cases, the EDs must be adequately staffed with sufficient providers to ensure access for patient care.  In contrast with other specialties in which providers offer services on a scheduled or as needed basis, ED compensation arrangements contemplate provider services in the context of a time-based (i.e., versus volume-based) approach.

That fact notwithstanding, the determination of FMV compensation for ED physicians and APCs presents unique challenges influenced by several factors, including ED crowding and the ongoing impact of the Covid-19 pandemic. EDs, often at the frontline of healthcare crises, experience fluctuating patient volumes and unpredictable demand for services, directly impacting the valuation of provider services.  ED crowding, an ever-present concern, can lead to extended patient LOS, increased medical errors, and heightened staff burnout, necessitating careful assessment by the valuator to determine FMV for healthcare professionals. The Covid-19 pandemic further amplified the strain on EDs, as they faced increased patient encounters/LOS, resource shortages, and unprecedented levels of stress on the healthcare workforce.

While ED provider compensation has typically been assessed on a coverage (i.e., shift) basis which often included subsidized professional collections, Covid-19 resulted in many facilities regularly utilizing “surge staffing”.  Not uncommon in ED staffing even prior to the pandemic, this type of model was used in combination with existing shift-based arrangements in the event a facility required resources on a basis that was greater than that initially anticipated.  While surge staffing existed prior to the pandemic, its use skyrocketed to meet increased demand associated with Covid-19.  This type of provider staffing generally involves compensation on an hourly basis to account for the unpredictability of the services required.  In the event a surge in patient volume occurs, ED management and/or medical directors can call on additional “surge” staffing by utilizing overtime or externally staffed providers at higher compensation rates.

In addition to flexible staffing models, a further anticipated change in ED staffing includes a greater utilization of APCs to provide patient care.  Not only do APCs leverage physician time and provide greater patient access, their compensation and benefits reflect a lower cost than that of physicians.  As hospitals continue to grapple with lessened financial margins and increased strain in the wake of the pandemic, a leveraged model using APCs may provide them an option to not only increase the number of providers offering care but also to do so in a less expensive format than a physician-only model (i.e., assuming that the quality of care continues at the same level).  As provider expenses continue to comprise the largest item of cost for hospitals, a lessening of these expenses may provide a win-win for both healthcare facilities and for patients.

While the industry continues to transform into its likely future state, provider staffing and compensation models will likewise evolve.  Greater use of tools not previously available will undoubtedly be a key consideration.  For instance, EDs were historically staffed with local providers, with a less than favorable availability for certain specialists in rural markets.  An increase in the use of telemedicine and data in the form of artificial intelligence (“AI”) will almost certainly continue into the future.  While the industry remains in a state of change, ED care will undoubtedly make use of new tools, ensuring adaptation within provider compensation models.  Outlined in the following table are some of the considerations that may differentiate future ED provider compensation models from those of the past.

 

 

 

These adaptations and challenges underscore the importance of valuing provider services in a manner that considers the dynamic nature of ED operations while maintaining compliance with regulatory guidelines. Additionally, the valuation must account for regional variations in ED volumes, payer mix, and available resources, as these factors can significantly influence the FMV of physician and APC compensation.  Ultimately, a comprehensive and nuanced valuation approach is essential to develop equitable compensation structures that support quality care delivery while addressing the complexities introduced by ED crowding, the pandemic’s impact, and other relevant variables.

 

Implications for the Future

Looking ahead, the challenges surrounding ED coverage present critical implications for the future of healthcare delivery.  The persistent issue of ED crowding which is exacerbated by demographic shifts, population growth, and evolving healthcare needs, is likely to continue pressuring medical facilities and professionals.  As the world grapples with the aftermath of the Covid-19 pandemic, the healthcare industry should brace itself for potential resurgences or future public health crises, demanding a prepared and resilient workforce.

In addition to provider access amongst increased patient demand, organizations will be tasked with addressing the financial impact of ED staffing challenges to ensure the sustainability of healthcare institutions, even in the face of mounting expenses and reimbursement complexities. Likewise, the valuator’s role will be increasingly crucial in shaping compliant compensation structures for physicians and APCs within ED settings, while also taking into account dynamic factors such as ED crowding, pandemic preparedness, regulatory compliance, and changes in coverage models.

To fortify emergency care, healthcare organizations, policymakers, and industry stakeholders must collaboratively explore innovative staffing models, optimize resource allocation, and invest in technology and telemedicine solutions to enhance efficiency and patient outcomes.  By proactively addressing these challenges and implementing sustainable solutions, the future of ED staffing and coverage will be better safeguarded, ensuring that quality care remains accessible, regardless of the uncertainties that lie ahead.

 

Closing Comments

To conclude, the challenges in ED staffing and coverage represent an evolving and multifaceted landscape that demands immediate attention and sustainable solutions.  ED crowding continues to stress resources, which in turn jeopardizes patient outcomes and contributes to escalating healthcare costs. The unprecedented impact of the Covid-19 pandemic further highlighted the vulnerabilities in emergency care, amplifying both workforce and financial burdens.  As if on cue, Envision’s bankruptcy – followed shortly thereafter by APP’s collapse – serves as a stark reminder of the risks faced by healthcare staffing firms and the need for prudent financial management.

A key element in this financial management involves provider staffing models and associated compensation.  Hospital administrators, valuation professionals, and counsel play a pivotal role in determining arrangement structure and ascertaining FMV compensation for emergency physicians and APCs alike.  While valuators and hospital management must navigate the complexities of ED operations and regulatory compliance, ensuring compliant compensation is a large part in the risk management efforts of healthcare organizations.

As the healthcare industry charts a course toward the future, strategic planning and collaborative efforts are essential to address these challenges. By embracing innovative staffing models, leveraging technology, and prioritizing patient-centered care, healthcare institutions can fortify their emergency care systems, ensuring that both patients and healthcare professionals receive the support they require.  A resilient and well-prepared ED workforce is fundamental to meeting the diverse and unpredictable demands of emergency medicine, safeguarding the well-being of communities and upholding a standard of excellence in healthcare delivery.

 

[1] As reported at https://www.envisionhealth.com/news/2023/envision-healthcare-reaches-restructuring-agreement.

[2] As reported at https://www.sciencedirect.com/science/article/pii/S2211419X20300707; citing, L.C. Carlson, T. Reynolds, L.A. Wallis, E.C. Hynes, Reconceptualizing the role of emergency care in the context of global healthcare delivery, Health Policy Plan, 34 (2019), pp. 78-82.

[3] 42 U.S. Code § 1395dd.

[4] Péterfi, A., Mészáros, Á., Szarvas, Z., Pénzes, M., Fekete, M., Fehér, Á., Lehoczki, A., Csípő, T., & Fazekas-Pongor, V. (2022). Comorbidities and increased mortality of covid-19 among the elderly: A systematic review. Physiology International, 109(2), 163–176. https://doi.org/10.1556/2060.2022.00206

[5] American College of Emergency Physicians Policy Statement.

[6] Lucero A, Sokol K, Hyun J, et al. Worsening of emergency department length of stay during the COVID-19 pandemic. J Am Coll Emerg Physicians Open 2021;2:e12489; as reported at https://onlinelibrary.wiley.com/doi/

10.1002/emp2.12489.

[7] As reported in the Wiley Online Library at https://onlinelibrary.wiley.com/doi/10.1002/emp2.12489#.

[8] Id.

[9] Institute of Medicine. Hospital-based emergency care: At the breaking point. Washington, D.C.: The National Academies Press; 2007

[10] As reported at https://catalyst.nejm.org/doi/full/10.1056/CAT.21.0217

[11] As reported at https://journals.lww.com/nursingmanagement/Fulltext/2005/09000/Nursing_workforce_issues_

and_trends_affecting.11.aspx.

[12] As reported at https://www.aha.org/fact-sheets/2021-11-01-data-brief-health-care-workforce-challenges-threaten-hospitals-ability-care.

[13] Id.

[14] As reported at https://www.bizjournals.com/nashville/news/2023/07/18/american-physician-partners-to-close.html.

[15] As reported at https://www.bloomberg.com/news/articles/2023-07-17/american-physician-partners-to-close-doors-after-cash-squeeze#xj4y7vzkg.

[16] As reported at https://www.modernhealthcare.com/finance/envision-healthcare-bankruptcy-staffing-no-surprises-act-unitedhealth-lawsuit.

[17] As reported at https://www.beckershospitalreview.com/hospital-physician-relationships/american-physician-partners-to-close.html

Healthcare Real Estate Transactions

Mountain Point Medical Center – Salt Lake City, UT.  JLL Capital Markets, Medical Properties Group announced the sale of Mountain Point Medical Center, a 60,000 square foot medical office building connected to the 40-bed Holy Cross – Mountain Point hospital in Lehi, Utah. The property is 100 percent leased to Centura Health, a non-profit faith-based health care system based in Colorado with 25 hospitals located throughout Colorado, Utah, and Kansas.

Charleston Cancer Center – Charleston, SC.  JLL Capital Markets announced it arranged the $10.1 million sale of the Charleston Cancer Center, totaling 26,256 square feet in Charleston, South Carolina at a 5.28% cap rate. The two-story, newly renovated medical office building is located at 2910 Tricom St. The property includes specialty treatment equipment including an infusion area, computed tomography (“CT”) imaging, lab, and an area on the second floor for clinical studies personnel. The Charleston Cancer Center is a single tenant clinical building with multiple cancer related specialties treated within the premises. The center was originally built in 2002 and has received renovations by both current ownership and tenant, RSFH, following Roper’s acquisition of Charleston Oncology.

Mission Critical Healthcare Facility – Providence, RI.  JLL Capital Markets announced it advised Sendero Capital and Angelo Gordon on the acquisition of 2 Wake Robin Road, a 30,000-square-foot medical office building in Providence, Rhode Island. The joint venture is focused on value-add and core plus outpatient medical office and surgery center assets throughout the Northeastern United States – a region with high barriers to entry, strong growth, and one of the largest concentrations of healthcare businesses in the U.S.  Constructed in 2006, 2 Wake Robin Road is a premier medical office building that is currently 96% leased to Lifespan Health System and clinical medical tenants offering a variety of services, including urgent care, primary care, imaging, pediatric care, physical therapy, and pathology. The building is located less than an hour from Boston and two national airports and is strategically positioned between Landmark Medical Center (6.6 miles) and Miriam Hospital (10 miles).

Healthcare Real Estate Recent Trends

 

 

MOB Sales drop and CAP Rates Increase since start of 2023.  According to the most recent statistics from Arnold, Md.-based Revista and its healthcare real estate (HRE) data service, RevistaMed, the MOB sales volume in the first half of 2023 fell 71 percent compared to the first half of 2022.  Revista’s Q2 Subscriber Webcast information provided MOB sales data showing that the preliminary volume in the second quarter (Q2) was just $1.2 billion, the lowest quarterly volume Revista has recorded since its founding in 2015.  When combined with the MOB sales volume of $1.7 billion in Q1, the first half of 2023 saw sales of only $2.9 billion, down, as noted, 71 percent from the $10.1 billion recorded in the first half of 2022.  It is worth noting that the records were established in multiple quarters of 2022.  Regarding Cap Rates for MOB, the information provided on Revista’s Webcast confirmed that Cap Rates are up approximately 60 basis points from this point last year on a trailing 12-month (TTM) average currently in the 6.5% Cap Rate range.

   

What will the next twelve months look like regarding the Healthcare Real Estate Industry?  The MOB Sales mentioned above is a fairly good indicator of trends for the healthcare real estate industry as a whole. The outlying “high water mark” of $12.8B in Q3 of 2022 seems like an anomaly. Understanding the previous record prior to $12.8B was $7.3B in Q4 of 2021 which at the time was unprecedented confirms that $12.8B was unusual and excessive. Now that this amount is in the rearview mirror, where is the industry heading now? From our perspective we believe we are in a period of correction to the overreaction with the past two (2) quarters being the lowest individually and collectively since these numbers were charted in 2015. Understanding that the current global issues and financial lending market situation will continue through the end of 2023, we expect these low and below average numbers will continue as well into the first (Q1) and possibly second quarter (Q2) of 2024. Regarding rental rates, we believe they have and will continue to stabilize in Q3 and will continue going forward. In addition, we believe the net effective rates that factor concessions such as abated rent will start to lower from previous quarters. Net effective rates are more difficult to confirm but we believe the trend of Landlords providing more concessions to tenants for new and renewal leases will continue through the end of 2023.

 

For more information, please contact Director Mike Vandaveer at MVandaveer@AskPHC.com, Director Chris Louis at CLouis@AskPHC.com, or Analyst Tony Price at TPrice@AskPHC.com.

Traditionally, carotid endarterectomy has been the primary method of treating high-grade asymptomatic and symptomatic carotid artery stenosis. However, a minimally invasive technique known as carotid artery stenting (“CAS”) has evolved over the years.  This technique offers reduced postoperative pain, reduced potential for postoperative wound complications, and shorter hospital stays.

On July 13, 2023, The Centers for Medicare and Medicaid Services (CMS) released a draft decision memorandum regarding carotid artery stenting that would expand coverage of the procedure and remove certain requirements for CAS facilities and operators.

The proposal is a result of a national coverage analysis for carotid artery stenting initiated by request of the Multispecialty Carotid Alliance (MSCA). The request was to make existing guidelines less restrictive and was initiated in January 2023. This proposal was considered and following release to public comments, 193 immediately followed.

  • The decision proposal will expand coverage for CAS “to standard surgical risk patients” by removing the limitation of coverage to only “high-surgical risk patients.”
  • Expanding coverage to individuals previously only eligible for coverage in clinical trials. Limit the coverage to patients for whom CAS is considered “reasonable and necessary” and who are either symptomatic with carotid stenosis of 50% or greater or asymptomatic with carotid stenosis of at least 70%.
  • Would require practitioners to “engage in a formal shared decision-making interaction with the beneficiary” that involves use of a “validated decision-making tool.” The conversation with the beneficiary must include discussion of all treatment options and their risks and benefits and cover information from the clinical guidelines, as well as “incorporate the patient’s personal preferences and priorities.”
  • Removing facility standards and approval requirements.
  • Allowing Medicare Administrator Contractor (MAC) discretion for all other coverage of Percutaneous Transluminal Atherectomy (PTA) of the carotid artery concurrent with stenting not otherwise addressed in National Coverage Determination (NCD) 20.7.

The proposed changes drastically differ from the original coverage criteria and are highly anticipated.  For more information regarding this proposed rule, contact Pinnacle Enterprise Risk Consulting Services, Robin Peterson, Manager of Professional Coding and Compliance Reviews, CPC, CPMA at RPeterson@AskPHC.com or Amy Pritchett, Manager HCC Coding/Audit & Education Services, CCS, CRC, CPA-RA,CPC, CPMA, CPCO, CDEI, CDEO, CDEC, CANPC, CASCC, CMPM, AAPC Approved Instructor, Approved ICD-10-CM/PCS Trainer at APritchett@AskPHC.com

COVID-19 public health emergency (PHE) ended on May 11, 2023.

Medicare’s coverage of telehealth for outpatient services will be extended through the end of 2024. Patients may continue to receive telehealth services no matter where they are in the United States and may receive services in their home rather than going to the health care facility.  Although private insurance often follows Medicare’s lead, they may decide to alter their telehealth coverage earlier.

 

Permanent Medicare Changes

  • Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs) can serve as a distant site provider for behavioral/mental telehealth services.
  • Medicare patients can receive telehealth services for behavioral/mental health care in their home.
  • There are no geographic restrictions for originating site for behavioral/mental telehealth services.
  • Behavioral/mental telehealth services can be delivered using audio-only communication platforms.
  • Rural Emergency Hospitals (REHs) are eligible originating sites for telehealth.

 

Temporary Medicare changes through December 31, 2024

The Consolidated Appropriation Act (CAA) of 2023 extended the following Telehealth flexibilities through December 31, 2024:

  • FQHCs and RHCs can serve as a distant site provider for non-behavioral/mental telehealth services.
  • No geographic restrictions for originating site for all other services except behavioral/mental telehealth services.
  • Medicare patients can receive telehealth services in their home.
  • Some additional telehealth services can be delivered using audio-only communication platforms. Refer to List of Telehealth Services for Calendar Year 2023.
  • An in-person visit within six months of an initial behavioral/mental telehealth service and annually thereafter is not required.
  • All eligible Medicare providers can provide telehealth services.

Additional Policy Changes and Updates:

  • Remote patient monitoring services (RPM) services could be provided to new and established patients during PHE, but following the end of the PHE, there must be an established relationship.
  • During PHE, RPM could be reported for as few as two days for COVID patients, but this reverts to 16 days after PHE.
  • CMS has not been enforcing LCDs on therapeutic continuous glucose monitors during the PHE to allow people with COVID and diabetes to monitor glucose and adjust insulin at home. This waiver ends with the PHE.
  • CMS decided to not enforce frequency limits for the rest of 2023 and to address them in future rulemaking.
  • CMS suspended plans to require physicians who provide services from their home to report their home address on their Medicare enrollment through the end of 2023 and will address in future rulemaking.
  • CMS has agreed to allow Merit-Based Incentive Payment System (MIPS)-eligible physicians to request hardship waivers for performance year 2023.
  • Laws about physician licensure will continue to defer to state law―no federal policy.
  • In response to AMA advocacy, CMS agreed to continue to allow teaching physicians to provide virtual supervision of residents through 2023 and will address future policy in future rulemaking.

 

Prescribing Controlled substance via telehealth:

  • Authorized providers can prescribe controlled substances via telehealth.
  • Telemedicine flexibilities regarding controlled substances that were in place as part of PHE will remain in place through November 11, 2023.
  • Provider patient relationships with telemedicine flexibilities established before November 11, 2023, as part of PHE will be permitted through November 11, 2024.

 

Telehealth Payment

Medicare will continue to pay telehealth services at the same rate as if the service had been provided in-person through the end of 2023. They will continue to pay for telephone E/M services (CPT codes 99441-99443) at rates of office visit established patient E/M codes of comparable length.

Medicare will revert to its pre-PHE telehealth payment rates on Jan. 1, 2024, meaning telehealth services will be paid at the facility rate rather than the non-facility rate. The Centers for Medicare & Medicaid Services (CMS) has not indicated whether it will change this policy, but more information should be available in the 2024 Medicare Physician Fee Schedule.

Medicare will continue paying for all codes on List of Telehealth Services for Calendar Year 2023, through the end of 2023. Future policy will be determined in the 2024 Medicare physician payment regulations.

 

Telehealth Visit Documentation

Clinical documentation plays a significant role in demonstrating compliance and establishing medical necessity.  Telehealth creates additional and specific documentation requirements.  These requirements continue after the end of PHE.

 

Documentation requirements:

  • Informed consent by patient or caregiver
    • Written-Member agrees to receive service via telehealth.
    • Verbal-is an acceptable method but must be documented in medical record.
  • Professional disclosure statement
    • Identity of the performing provider.
    • Current provider location.
    • Current patient location.
    • Telephone number.
    • ID license number as applicable.
  • Treatment record
    • Mode of delivery – via telehealth (secure two-way interactive video connection, phone call, etc.).
    • Indicate HIPPA secure platform used.
    • Identification of service being supplied.
    • List anyone present – with confidentiality form on file.
    • Document and develop evaluation processes and participant outcomes.
    • Normal Evaluation and Management.
    • Time spent in medical discussion to support the procedure code billed, include start and stop times if required for service.

Example documentation of consent, platform and mode of telehealth service:

“This appointment was requested by the patient as a <telephone or audio video> using <indicate HIPPA secure platform> visit with consent obtained from <patient name> to discuss <conditions or reason for visit>.  Patient is located at <home or other location> the provider is located at <office/home/other>.  The patient has been informed the visit will be billed as allowed by their insurance and may incur a copay. List any additional parties involved during the call with patient and patient consent to participate.

 

Supporting note documentation:

  • Date of service/call.
  • Subjective/objective findings.
  • Diagnosis or condition discussed with referrals, recommendations, and/or treatment plan.
  • Time spent in medical discussion with the patient or caregiver start and stop times or total time.

While mental health awareness month occurred in May, we need not forget the upcoming changes to Medicare Advantage members in CY 2024 and beyond.

On March 31, 2023, The Centers for Medicare and Medicaid Services (“CMS”) released the CY 2024 Advance Notice for Medicare Advantage and Part D.  This advance notice will change everything we know about Risk Adjustment and Hierarchical Condition Category (HCC) Coding.

In the final notice, CMS deleted forty (40) ICD-10-CM diagnosis codes that currently map to an HCC in version 24 that will no longer map to a payable HCC in version 28. The change means that beginning January 1, 2024, all mental health codes under HCC (55 and 59) will no longer carry a risk adjustment score weight.  Below, are just a few examples of how the migration from v24 to v28 will play a major role in how we receive reimbursement for mental health codes.

  • 120, “Alcohol abuse with intoxication, uncomplicated” in CMS-HCC v24 maps to HCC category 55 with a risk adjustment factor of 0.329 and a monthly premium of $263.00. In CMS-HCC v28, it will now map to no HCC, carry no risk adjustment factor, thus impacting the monthly premium to $0.00.
  • 70, “Bipolar disorder, currently in remission, most recent episode unspecified” currently maps to HCC category 59 with a risk adjustment factor of 0.309 and a monthly premium of $247.00. In v28 model, it will no longer map to an HCC, carry no risk adjustment factor, and affect the monthly premium to $0.00 reimbursement.

We are all asking ourselves, why the drastic change? Why now? CMS updates the risk adjustment models consistently to reflect the utilization and cost patterns for Medicare Advantage (“MA”) beneficiaries.  Clinical revisions are updated to revise the composition of condition categories required to reflect changes in disease patterns, treatment methodologies, and coding practices.  The update to the CMS-HCC model perpetuates the need for reclassification for changing risk adjustment payment models based on ICD-10-CM diagnoses codes.  The model change for CY 2024 resulted in a more appropriate relative weight for HCCs contained in the model due to the utilization, coding, and expenditure patterns in Medicare Fee-for-Service along with clinical cost patterns associated with those associated ICD-10-CM codes.  The current v24 model was based on the ICD-9-CM classification system, which did not account for the creation of the ICD-10-CM classification system, therefore, many of the diagnosis codes were obsolete.  The risk adjustment model update utilized the most recent CMS-HCC risk adjustment model utilizing claims from 2014 and 2015, moreover the current model is utilizing the same years claims for diagnoses and expenditure reliability.

For the first time, CY 2024 will utilize a model that fully incorporated the clinical revision of HCCs using ICD-10-CM diagnosis codes.  All previous versions of the CMS-HCC model utilized ICD-9-CM diagnosis codes to create the models. Based on this information, the CMS-HCC model will undergo a massive reclassification to better reflect diagnosis coding under the ICD-10-CM diagnosis classification system. Of the numerous changes to condition categories in v28, several additions, deletions, and revisions were related to each condition category, along with the ability to predict costs for Medicare Part A and B beneficiaries.  The condition categories also eliminated the categories that did not predict costs, coefficients, or further specified diagnostic codes, which were eliminated from the v28 model.

Provider documentation will now take center stage as the variation of coding will no longer be allowed for discretionary conditions.  Under Principle 10, which has been the standard evaluation of all risk adjustment models, the final notice stated, ”Coding these conditions is likely not consistent across the industry- including them in the risk adjustment model can lead to distortion of the marginal costs estimated by the model, reducing the ability of the HCCs in the model to predict stable costs and accurately predict those costs in alignment with the severity of the condition.”  [1]

When CMS focused on Principle 10 for the CY 2024 update, they identified numerous diagnosis and condition categories that needed reclassification due to relative coding under Medicare Advantage plans, whereas the Fee-for-Service plans were based on clinical input to code each condition.  Many of the HCC categories have either been revised, deleted, or the coefficient constraints have been restructured. Below, we highlight some of the changes and summarize the effects of the new model.

 

2020 Model (v24)2024 Model (v28)
86 payment HCCs

9,797 FY22/FY23 ICD-10 diagnosis codes mapped to an HCC for reimbursement

115 payment HCCs

7,770 FY22/FY23 ICD-10 diagnosis codes mapped to an HCC for reimbursement

Cognitive Disease Group: 2 HCCsCognitive Disease Group: 3 HCCs
HCC 51 (Dementia with Complications)

HCC 52 (Dementia without Complications)

HCC 125 (Dementia, Severe)

HCC 126 (Dementia, Moderate)

HCC 127 (Dementia, Mild or Unspecified)

Substance Use Disorder Disease Group: 3 HCCsSubstance Use Disorder Disease Group: 5 HCCs
HCC 54 (Substance use with Psychotic Complications)

HCC 55 (Substance use disorder, moderate/severe, or Substance use with Complications)

HCC 56 (Substance use disorder, mild, except alcohol and cannabis)

HCC 135 (Drug use with psychotic complications)

HCC 136 (Alcohol use with psychotic complications)

HCC 137 (Drug use disorder, moderate/severe, or drug use with non-psychotic complications)

HCC 138 (Drug use disorder, mild, uncomplicated, except cannabis)

HCC 139 (Alcohol use disorder, moderate/severe, or alcohol use with specified non-psychotic complications)

Psychiatric Disease Group: 4 HCCsPsychiatric Disease Group: 5 HCCs
HCC 57 (Schizophrenia)

HCC 58 (Reactive and unspecified psychosis)

HCC 59 (Major Depressive, Bipolar, and Paranoid disorders)

HCC 60 (Personality Disorders)

HCC 151 (Schizophrenia)

HCC 152 (Psychosis, except schizophrenia)

HCC 153 (Personality disorders; Anorexia/Bulimia Nervosa)

HCC 154 (Bipolar Disorders without psychosis

HCC 155 (Major Depression, moderate or severe, without psychosis)

 

As you notice, many of the HCC groups from the v24 model have been expanded to include more detailed descriptions under the v28 model.  In many ways, the expansion is good for code capture; however, in many instances it is not.  Fortunately, Pinnacle has the knowledge and tools to navigate you through the model change and assist with the conversion.  Pinnacle offers coding, auditing, and educational services pre and post implementation! Please contact Amy Pritchett, Manager HCC Coding/Audit & Education Services, at APritchett@askphc.com for more information.

 

[1] (https://www.cms.gov/files/document/2024-advance-notice-pdf.pdf).

Pinnacle has reviewed the proposed rule changes for CY2024 related to the Medicare Physician Fee schedule.  CMS has also published a fifteen (15) fact-sheet summary.  The condensed overview below was constructed to provide an at-a-glance topic list of the proposed changes awaiting public comment before it is finalized.  We hope this is helpful to allow our colleagues to peruse the list and investigate further any details that may affect their practice.

  • Medicare Conversion factor: decreased from $33.89 (2023) to $32.75 (2024), representing an across the board decrease in reimbursement of 3.34%.
  • Supporting & expanding patient access and care integration initiatives:
    • In support of Access to High Quality Care & Supporting Caregivers, proposed payment when practitioners train and involve caregivers to support patients with certain diseases.
    • Payment and code changes to report Community Health Integration (CHI), Social Determinants of Health (“SDOH”) Risk Assessments, and Principal Illness Navigation (PIN) services by additional auxiliary personnel (community health workers, care navigators and peer support specialist) when provided ‘incident to’ a billing practitioner.
      • Additionally, we are proposing to add the SDOH risk assessment to the annual wellness visits as an optional element which will include additional reimbursement.
      • We are also proposing codes and payments for SDOH risk assessments furnished on the same day as an E/M visit.
    • These types of services are the first to be covered and support patient navigation of their healthcare access and options. Remember new opportunities for reimbursement create risk, therefore it will be important to understand what is required, compliance with requirements and how it impacts revenue.
  • Evaluation and Management add on code: HCPCS code G2211 is expected to be available in CY2024 to enhance payments to primary care and longitudinal care of complex patients. It was delayed due to public comment and the expected great impact on other service reimbursement and specialty providers to remain budget neutral, meaning if a provider type gets more money, it results in less 1:1 for other provider types.
  • Split/Shared Evaluation & Management (“E/M”) visit reporting rule delayed until at least CY2025: A hot topic for many physicians nationwide, delayed changing Split/Shared E/Ms reporting from ‘substantiative portion’ being billed under the physician involved in the visit supported by evidence of their involvement in documentation to solely being the provider spending more time on the visit. As it is common for advanced practice providers (“APP”), such as nurse practitioners and physician assistants, to spend more time on each visit, currently if the physician documents impacting care in a substantiative way, it can be billed by the physician.  Since many medical organizations and physician groups use APPs to make seeing patients more efficient, the APP will typically spend more time which under the change would decrease reimbursement and credit for their work by 15%.  Many strongly oppose this change and has now been delayed from implementation since first seen in the CY2022 final rule.
  • Telehealth Services: notable changes, extensions and continued flexibility are:
    • Adding well-being coaching services (temporarily)
    • Adding SDOH Risk Assessments
    • Including Occupational, Physical and Speech Therapists and Audiologists as telehealth eligible (temporarily)
    • Expansion of originating sites to include anywhere in the USA where the beneficiary is at the time of service (temporarily)
    • Continued payment for RHC and FQHCs services implemented under PHE (temporarily)
    • Delay to in-person requirement (within 6 months) prior to telehealth mental health services
    • Continued coverage of Medicare Telehealth Services List through CY2024
    • Reimburse telehealth at non-facility rates.
    • Supervision by audio-video interactive telecommunications through CY2024, including some teaching physician services.
    • Expanding DSMT delivery allowances as telehealth services.

In addition, CMS is seeking public comments that would further extend, or even make permanent, many of the above.

  • Mental / Behavioral Health:
    • Adding Marriage & Family Therapists (MFT) and Mental Health Counselors including addiction counselors (MHC) as billing providers starting after the final rule and not before Jan. 1, 2024 (Also, will apply to RHC and FQHCs and have additional leniency in these settings). MFT and MHC will be added to Behavioral Health Integration (BHI) codes in the primary care setting. Health Behavior Assessment and Intervention (HBAI) codes to be billed by Clinical Social Workers (CSW), MHC and MFTs.
    • Will include new HCPCS code for psychotherapy for crisis services.
    • Additionally, some of the mental and behavioral health codes may see an increase in value to further foster more resources and better access to its beneficiaries.
    • Opioid Treatment Programs would see the audio only flexibilities through CY2024 for periodic assessments.
  • PT/OT (private practice): Some supervision leniency from direct to general supervision is proposed for therapy assistants for certain services. CMS is seeking comments on those changes and the effects of making them permanent.
  • Dental: CY2024 will expand dental care coverage in limited circumstances- patients with head and neck cancer and -other cancer patients where dental health is impacted due to cancer treatments.
  • Drugs and Biologicals paid under Part B: Provides for adjustment to both Medicare payment amounts and Beneficiary liable coinsurance and deductibles for medications in certain circumstances. Seeking comments regarding coverage for some self-administered drugs and complex therapeutic for coding/payment consistency purposes.
  • Clinical lab fee schedule: Limits payment reductions for laboratory testing of not more than 15% from the preceding year.
  • Preventative Vaccines in home: extending coverage of COVID vaccine and expanding coverage to flu, pneumococcal and hepatitis B vaccines given in the home setting. Payment amount for all four (4) vaccines administrations will be the same and CMS is proposing to limit the additional payment to one payment per home visit.
  • Medicare Diabetes Prevention Plan: Extending for four (4) years the ability for MDPP suppliers to continue offering their services virtually.

There are additional topics within the CMS fact sheet and in the published proposed rule for CY2024.  For more details on any topic within this article, the links for the official site are offered in the reference and additional resources section below.  We appreciate your feedback.  Our goal was to save our readers time by further condensing some of the most important topics for the professional-fee industry readers.

References and Additional Resources:

In a time where healthcare costs continue to rise, there is a diverse range of payment models in use, ranging from traditional fee-for-service to global capitated payment, to stunt the growth in costs. The Health Care Payment Learning & Action Network (HCP-LAN) has identified four main categories of payment (as shown in Table 1)[1]. The primary objective of promoting value-based payment is to shift as many providers and as much revenue as feasible into the third and fourth categories.

The 2022 Alternative Payment Model (APM) results from the HCP-LAN, resulted in the following:

Shared savings contracts have emerged as a promising approach to promote cost-effective and high-quality care delivery. These contracts incentivize healthcare providers to achieve cost savings while improving patient coordination and outcomes.

A shared savings contract is an agreement between healthcare payers and providers that aims to reduce healthcare costs by sharing the financial benefits resulting from cost savings. Providers are rewarded when they achieve cost reduction targets through smarter spending while maintaining quality benchmarks. This innovative payment model fosters collaboration between payers and providers, aligning their interests towards cost-efficient care delivery. Shared savings arrangements can range from private commercial insurance to working with the government/Medicare.

 

Different Shared Savings Arrangements

Shared savings contracts encompass a range of diverse structures, allowing healthcare providers to choose the arrangement that best suits their organization’s goals and capabilities. One option is to enter into commercial contracts with private payers which involves negotiations and agreements directly with insurance companies. Another avenue for participation is through the Medicare Shared Savings Program (MSSP), a government initiative that aims to promote accountable care and cost savings within the Medicare population. MSSP provides a regulatory framework and support for providers to transition to value-based care and engage in collaborative efforts with other healthcare stakeholders. Bundled payment arrangements are another type of shared savings contract. In this model, providers are reimbursed a fixed payment for an entire episode of care, encompassing all services and treatments related to a specific condition or procedure. Bundled payments encourage coordinated and efficient care delivery across different healthcare providers involved in the patient’s journey with the goal of reducing costs and improving outcomes.

When considering participation in a shared savings contract, it is essential to carefully evaluate the requirements and criteria of each arrangement. Commercial contracts may involve different payment methodologies and quality benchmarks while MSSP requires adherence to specific program guidelines and reporting requirements. Bundled payment arrangements require collaboration and coordination with other providers within the episode of care. By evaluating the alignment of each arrangement with organizational goals, capabilities, and resources, providers can make informed decisions about which shared savings contract is most suitable for their practice or institution.

Ultimately, participating in a shared savings contract offers an opportunity for healthcare providers to enhance care quality, reduce costs, and improve patient outcomes. By selecting the right arrangement and understanding its unique requirements, providers can actively contribute to the transformation of healthcare delivery towards a more value-based and patient-centered system.

 

Components of Shared Savings Contracts

Shared savings contracts typically involve the following key components:

a) Attribution: Attribution rules play a crucial role in shared savings contracts as they determine which providers are responsible for the care and outcomes of a specific patient population. Clear and well-defined attribution methodologies are essential to ensure fairness in distributing shared savings among accountable providers. Accurate attribution allows for a more comprehensive evaluation of the impact of provider interventions and facilitates accountability for patient care.

b) Benchmarking: Establishing performance benchmarks is a critical aspect of shared savings contracts. These benchmarks serve as reference points against which providers’ performance is measured. By comparing current performance to predetermined benchmarks, providers can assess the progress made in achieving cost savings and quality improvements. Benchmarks can be based on various factors, such as historical spending patterns, regional or national averages, inflation, evidence-based guidelines, or other relevant metrics that reflect the goals and objectives of the shared savings contract.

c) Care Coordination Fees: Shared savings contracts often include care coordination fees as an additional component. These fees are designed to incentivize effective care coordination efforts among providers. Care coordination plays a vital role in achieving cost savings and improving patient outcomes by ensuring seamless transitions of care, reducing duplicative services, and enhancing care continuity. By providing these financial incentives for care coordination, providers can invest time and resources in implementing care coordination strategies, which ultimately contribute to better patient outcomes and reduced healthcare costs. Care coordination fees are often allocated as upfront shared savings to support the necessary infrastructure costs associated with implementing care coordination initiatives. Typically, these fees fall within a range of $2.50 to $7.00 per member per month, providing financial support for the coordination efforts required to achieve cost savings and enhance patient outcomes.

Effective implementation of these components requires collaboration among various stakeholders, including payers, providers, and care teams. Clear communication and understanding of the attribution rules, transparent benchmarking methodologies, and appropriate compensation for care coordination efforts are essential for successful shared savings contract implementation. By incorporating these key components into shared savings contracts, healthcare providers and payers can align their efforts to drive positive change in healthcare delivery, leading to improved outcomes, increased efficiency, and reduced costs.

 

Preparing to Participate in a Shared Savings Contract and Mitigate Risk

Before entering into a shared savings contract, thorough preparation is essential to maximize the chances of success. Consider the following factors:

a) Know the Rules: Take the time to thoroughly understand the specific rules and requirements of the shared savings arrangement you are considering. Familiarize yourself with the contractual obligations, reporting mechanisms, performance metrics, and any quality benchmarks that need to be met. Familiarize yourself with the benchmarks that will be used to measure your performance and determine the amount of shared savings achieved. This understanding will enable you to comply with the contractual requirements and optimize your performance.

Knowing the rules and regulations governing the shared savings contracts is crucial for mitigating risk. By understanding the contractual obligations, reporting requirements, and performance metrics, healthcare providers can ensure compliance and avoid penalties. Additionally, being well-versed in the rules allows organizations to leverage best practices such as care coordination, data analytics, and patient engagement strategies to optimize outcomes, improve quality, and achieve shared savings.

b) Know Your Population: Knowing which patients are attributed to you is a fundamental aspect of participating in a shared savings contract. Understanding the attribution methodology utilized by the contract is essential for several reasons. First, it enables you to accurately assess the patient population for whom you will be responsible, allowing you to focus on delivering the most appropriate and effective care. Attribution may be based on various factors such as primary care physician assignment, patient choice, or utilization patterns. By understanding the attribution rules, you can identify the individuals for whom you will be accountable and ensure that you have the necessary resources and capabilities to meet their healthcare needs.

In addition, gain a deep understanding of the characteristics, needs, and healthcare utilization patterns of your patient population. Analyze data on demographics, prevalent conditions, and utilization patterns to identify areas of high cost and opportunities for improvement. This knowledge will help you develop targeted interventions and strategies that are tailored to the specific needs of your population.

c) Knowing Your Spend: Conduct a comprehensive analysis of your organization’s spending patterns. Identify areas of high expenditure, such as readmissions, unnecessary procedures, or inefficient care transitions. By understanding your spending patterns, you can pinpoint opportunities for smarter spending and implement interventions that address these specific areas.

Participating in a shared savings contract is a strategic approach to delivering cost-effective and high-quality care. By understanding the concept, evaluating different arrangements, comprehending the key components, and adequately preparing, healthcare providers can navigate the complexities of shared savings contracts successfully. With the potential to benefit both patients and healthcare organizations, shared savings contracts foster a culture of collaboration and accountability, driving improvements in healthcare delivery.

 

Distribution of Shared Savings

The distribution of shared savings among participating providers is a critical aspect of shared savings contracts. The methodology for distribution can vary depending on the specific contract and the participating providers.

One common approach to distributing shared savings is based on panel size/attribution and predetermined Key Performance Indicators (KPIs) that effectively capture smarter spending and quality improvement. These KPIs are typically agreed upon at the beginning of the contract and serve as the basis for evaluating providers’ performance. Examples of KPIs may include increased Annual Wellness Visits (AWVs), coordinate transitions of care (inpatient and outpatient facilities), reduced hospital readmissions, improved management of chronic conditions, increased preventive care utilization, or patient satisfaction ratings.

The distribution methodology may involve assigning weights to each KPI, reflecting their relative importance in achieving the overall goals of the contract. Providers who meet or exceed the performance targets for these KPIs are typically eligible to share in the savings generated. The distribution can be based on a percentage of the achieved savings or on a predetermined formula that takes into account each provider’s contribution to the overall cost reduction through coordinated care, smarter spending, and quality improvement. Shared savings can be distributed through various methods. This may include direct financial incentives or bonuses based on individual or group performance. Alternatively, the organization may choose to reinvest a portion of the shared savings into resources and infrastructure that support ongoing quality improvement efforts.

 

Determining Fair Market Value of Physician Services under Value-Based Initiatives

Compensation paid to physicians for any service, whether clinical or administrative, is included within the financial statements for that physician practice and ultimately on an IRS Form W-2 or K-1 (net of expenses). While some compensation reporting agencies try to break out certain forms of compensation from total cash compensation, in general, all forms of compensation are included in benchmark data.

The fair market value of physician services under value-based initiatives becomes a little bit of a carrot versus a stick type of question. Quality, efficiency, and shared savings payments are generally paid based on the achievement of certain metrics and possibly remuneration from payors for achieving certain goals. The benchmarks report that this compensation has slowly increased from 5% to almost 8% on average of total compensation. This compensation is only what was earned as opposed to the maximum available funds achievable by maximizing success under a value-based program. Quality compensation can also vary significantly based on the acuity weighting of the practice’s patient population, the adoption of value-based payor contracts by the provider entity and payors, and the achievement of goals.

The Stark Law specifically refers to the term “aggregate compensation” and the determination of whether aggregate compensation is consistent with fair market value for the services provided. One of the biggest concerns in assessing if compensation is consistent with fair market value is verifying that the provider is not paid for certain services, such as case coordination or performance of an annual wellness visit, and also receiving compensation for shared savings generated by these efforts.

Base CompensationProductivity BonusIncentive CompensationQuality BonusShared SavingsTotal Compensation
Physician A$250,000$50,000$10,000$25,000$100,000$435,000

Under this compensation plan, a primary care physician would earn over the 90th percentile compensation. At around 6,000 wRVUs, the physician would be compensation at around the 75th percentile compensation per wRVU. Incentive compensation is paid for wellness visits, care coordination, and advanced practice provider supervision. Shared savings are generally paid as a percent of actual shared savings achieved ranging from 50% to 80%.

Overall, fair market value for services provided under value-based initiatives should be checked for duplication of payment, comparison to benchmarks, and aggregate compensation.

 

Conclusion

Over the past decade, significant progress has been made in transitioning the healthcare system from fee-for-service payment to value-based payment. The Centers for Medicare and Medicaid Services (CMS) and other payers have successfully shifted away from outdated payment models. Many providers are now involved in quality-linked payment arrangements, and some have even started exploring advanced forms of population-based payment and practice transformation.

In the next decade, it is crucial to apply the lessons learned by engaging providers who have been slower to adopt value-based payment, scaling up successful APMs that are already in use, driving payment and practice transformation in commercial insurance, and prioritizing equity in value-based payment strategies. Achieving a sustainable healthcare system that pays for better quality, equity, and efficiency is an ambitious yet entirely attainable goal that starts with understanding shared savings contracts/arrangements, and making them more impactful and efficient.

For more information, please contact Curtis Bernstein, Kelly Conroy, or Daniela Yusufbekova.

[1] Measuring Progress: Adoption of Alternative Payment Models in Commercial, Medicaid, Medicare Advantage, and Traditional Medicare Programs. Health Care Payment Learning & Action Network. Retrieved from http://hcp-lan.org/workproducts/apm-methodology-2022.pdf

Modifier 25 Scenarios

Is your documentation up to par to support Modifier 25? First, you should read The Center for Medicare and Medicaid Services (CMS) National Correct Coding Initiative (NCCI) chapter manual guidelines. Check out chapter 1 and chapter 11.

The CPT Manual defines modifier 25 as a “Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service.” Modifier 25 may be appended to an evaluation and management (E&M) CPT code to indicate that the E&M service is significant and separately identifiable from other services reported on the same date of service. The E&M service may be related to the same or different diagnosis as the other procedure(s).  Yes, you read that correctly – you DO NOT have to have a separate diagnosis code!

Modifier 25 may be appended to E&M services reported with minor surgical procedures (with global periods of 000 or 010 days) or procedures not covered by Global Surgery Rules (with a global indicator of XXX). Since minor surgical procedures and XXX procedures include pre-procedure, intra-procedure, and post-procedure work inherent in the procedure, the provider/supplier shall NOT report an E&M service for this work.

  • That means the decision to perform a minor surgical procedure does NOT support modifier 25.
  • This rule applies to both New and Established patients.
  • The E&M service and minor surgical procedure do NOT require different diagnoses.
  • The NCCI program contains many, but not all, possible edits based on these principles.

 

Clinical Examples

Case #1: 34 y/o new patient presents to the Dermatologist with a complaint of an irritating skin tag. The provider examines the area and decides to perform cryotherapy on skin tag. The decision to perform this minor surgical procedure is included in the global period of the minor procedure.

  • This does NOT support modifier 25 with an E/M visit. Only the procedure should be coded.

Case #2: 55 y/o new patient is seen for bilateral knee pain. Patient says right knee is worse than left knee. The provider orders a bilateral knee x-ray. X-ray confirms DJD in both knees. The provider decides to perform a knee joint injection in the right knee since the patient feels the left knee isn’t that painful.

  • This DOES support a separate E/M with modifier 25 for the left knee since the provider orders an x-ray and doesn’t decide to perform a minor procedure on this knee. The joint injection procedure will be coded, and the right knee pain diagnosis will be linked to the procedure. Left knee pain diagnosis should be linked to the separately identifiable E/M on the same day.

Case #3: 25 y/o established patient comes in for a skin check and has moles on the back and arms the patient would like the provider to examine. The provider performs a full body skin exam. The provider decides to perform a skin biopsy on an abnormal looking mole on the back.

  • This DOES support a separate E/M with modifier 25 for the moles on the arms and back that the provider examined but didn’t perform any procedure. The provider would also code for the skin biopsy for the abnormal looking mole on the back.

Case #4: 40 y/o with right sided breast cancer returns for a follow up visit. Patient is doing well with no complaints. The provider reviews blood count and the patient proceeds with chemotherapy today.

  • This does NOT support modifier 25 on an E/M service with same day chemotherapy. The decision to proceed with chemotherapy is included in the infusion administration pre-service work.

Case #5: 36 y/o established patient was seen last week as a new patient and diagnosis with non-small cell lung cancer. Patient returns today without any new complaints. The provider conducts chemotherapy teaching and then the patient proceeds with chemotherapy infusion.

  • This does NOT warrant a separate E/M service on the same day as the chemotherapy administration. Chemotherapy teaching is bundled into the administration of the drug. If the provider had performed the chemotherapy teaching at the new patient visit this could have been factored into the medical decision making for the time spent on that day.

Remember, if you are reporting an E/M with modifier 25 on the same day as a minor procedure, the E/M should include work above and beyond the usual preoperative and postoperative services associated with the minor procedure performed on the same date of service. The AMA has developed a checklist of the typical pre- and post-operative services associated with a minor procedure that can NOT be reported as a separate E/M service. Those items include:

  • Review of patient’s relevant past medical history,
  • Assessment of the problem area to be treated by surgical or other service,
  • Formulation and explanation of the clinical diagnosis,
  • Review and explanation of the procedure to the patient, family, or caregiver,
  • Discussion of alternative treatments or diagnostic options,
  • Obtaining informed consent,
  • Providing postoperative care instructions, and
  • Discussion of any further treatment and follow up after the procedure.

For more information on coding compliance review services, please contact Pinnacle Enterprise Risk Consulting Services Director Lori Carlin at LCarlin@AskPHC.com.

Resources:

https://www.cms.gov/medicare-medicaid-coordination/national-correct-coding-initiative-ncci/ncci-medicare/medicare-ncci-policy-manual

https://www.ama-assn.org/system/files/reporting-CPT-modifier-25.pdf

The Centers for Medicare and Medicaid Services (“CMS”) utilize risk adjustment factors to estimate the cost of Medicare Advantage (“MA”) beneficiaries and those associated costs of providing care.  Risk adjustment factor scores govern the amount paid by the health plan during the year for the beneficiary’s care.  The risk adjustment scores factor in demographic and specific life and health information such as the beneficiary’s:

  • Age
  • Biological Sex
  • Geographical location
  • Dual coverage eligibility
  • Acquired health status
  • The presence and active nature of multiple chronic conditions whose level of severity are much greater, and the estimated cost to treat the beneficiary are estimated at higher benchmarks.
  • Active medications

CMS released the “Advanced Notice of Methodological Changes for CY 2024” on May 1, 2023.  The change will affect MA capitation rates along with Part C and Part D payment policies.  The Advanced Notice describes the drastic changes to the MA risk adjustment model, from Version 24 to Version 28.

CMS noted the change from Version 24 to Version 28 was initiated to better align with Medicare Fee-For-Service (MFFS) to clinically identify those conditions which may have a coding variation.  In the latter portion of CY 2022, CMS released numerous audit findings noting the Risk Adjustment Model included ICD-10-CM diagnosis categories that could include variations leading to inappropriate assignment by providers.  CMS also cited that the diagnosis codes did not provide a clear picture of future cost predictors.  This, along with the Hierarchical Condition Categories (“HCC”) payment models becoming insignificant, including diagnoses that were rarely seen, did not meet coding specificity criteria.

The Centers for Medicare & Medicaid Services (CMS) HCC model was initiated in 2004 and is becoming increasingly prevalent as the environment shifts to value-based payment models.

The Hierarchical Condition Category (HCC) coding relies on ICD-10-CM coding assignment to translate to risk scores for patients. An HCC is mapped to a specific ICD-10-CM code.  The current HCC model has been used with minor updates year after year but remained standard since 2015.  However, with the initiation of Version 28, there will be a significant change to that model.  This will affect the way we do business across MA plans.

Once the new Version 28 (“V28”) is released, provider documentation will be even more critical to assign the best and most proper code to capture the most accurate HCC assignment.  This is because the volume of ICD-10-CM codes are going to be reduced and may affect the scores of a large percentage of beneficiaries who may have scores higher than they would after the V28 change.

One of the largest changes to the RA model for CY2024 is the expansion of HCC categories from 86 to 115.  However, with the deletion of 2,194 diagnosis codes that risk currently adjust, the same conditions will no longer lead to additional payment.  For example, in V28 Diabetes will limit the coefficient categories that also currently carry the same HCC weight, because CMS adjusted all the relative factor weights for diabetes codes and reclassified them into four (4) levels instead of three (3).  Additionally, the risk adjustment model is going to drop solid organ transplants and instead, will classify under the specific body system.

In another example, diabetes with peripheral vascular disease carried a risk adjustment weight of 0.302 in V24 with the addition of the disease coefficient of 0.288 for peripheral vascular disease.  However, in the V28 model, diabetes has been recalculated to a lower risk adjustment score of 0.166 and no longer contains the disease coefficient interaction for peripheral vascular disease, This change, which is a common condition in member populations that currently risk adjust results in V28 lowering the risk adjustment score by (0.424) for its reimbursement calculation.

It will be imperative to capture disease interactions such as type II diabetes with congestive heart failure to receive what the coefficient amounts where in V24, underlying complications of diabetes also calculated to a coefficient.

For more examples of how this change will affect reimbursement, or if you have any questions about your HCC Coding, please contact Amy Pritchett at APritchett@AskPHC.com.